XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Operating Activities:    
Net loss $ (12,649,292) $ (33,479,378)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,012,183 3,180,529
Share based compensation 108,717 708,776
Warrant expense 335,739 0
Realized gain on sale of assets (1,199,606) 0
Amortization of financing costs to interest expense 73,018 125,902
Write down of previously capitalized inventory 363,758 0
Non-cash interest expense 1,273,087 298,149
Amortization of debt discount 3,656,430 4,437,611
Change in fair value of derivatives and (gain)/loss on extinguishment of liabilities, net (3,753,465) 7,928,578
Inducement conversion costs 635,514 0
Bad debt expense 514 246,116
Changes in operating assets and liabilities:    
Accounts receivable 545,481 1,506,462
Inventories 1,139,001 813,735
Prepaid expenses and other current assets 493,008 497,325
Accounts payable (1,469,670) 382,738
Related party payable (13,287) 0
Accrued expenses (850,314) 238,768
Accrued litigation settlement (339,481) (401,268)
Warranty reserve (71,355) (34,834)
Net cash used in operating activities (10,710,020) (13,550,791)
Investing Activities:    
Purchase of property, plant and equipment (6,402) (40,262)
Proceeds from the sale of assets 150,000 0
Patent activity costs (50,898) (152,076)
Net cash provided by/(used in) investing activities 92,700 (192,338)
Financing Activities:    
Payment of debt financing costs (20,000) (40,000)
Repayment of debt (1,785,597) (211,648)
Proceeds from the issuance of promissory notes 2,865,000 300,000
Proceeds from convertible notes 1,500,000 2,000,000
Proceeds from Committed Equity Line 0 1,056,147
Proceeds from issuance of stock and warrants 9,010,000 10,405,000
Net cash provided by financing activities 11,569,403 13,509,499
Net change in cash and cash equivalents 952,083 (233,630)
Cash and cash equivalents at beginning of period 130,946 326,217
Cash and cash equivalents at end of period 1,083,029 92,587
Supplemental Cash Flow Information:    
Cash paid for interest 1,120,350 267,666
Non-Cash Transactions:    
Non-cash conversions of preferred stock and convertible notes to equity 10,914,988 9,236,810
Make-whole provision on convertible preferred stock 257,152 0
Non-cash financing costs 2,500 0
Accounts payable converted to notes payable 1,637,260 0
Accounts payable forgiven related to sale of EnerPlex 1,031,726 0
Interest converted to principal 104,199 0
Common shares issued for commitment fee $ 63,750 $ 0